鄰近類別 圖書 [1/1] 會議論文/會議摘要 [10/11] 專利 [0/24] 類別統計 近3年內發表的文件:18(15.93%) 含全文筆數:110(97.35%) 文件下載次數統計 下載大於0次:110(100.00%) 下載大於100次:106(96.36%) 檔案下載總次數:62579(92.23%) 最後更新時間: 2024-12-11 16:23 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Boosting DNA vaccine power by lipid... ADAM9 drives the immunosuppressive ... Inhibition of ADAM9 promotes the se... Lipid nanoparticle-encapsulated DNA... A broad-spectrum pneumococcal vacci... Co-delivery of a trimeric spike DNA... A TLR9 agonist synergistically enha... TLR9 and STING agonists cooperative... Recombinant lipidated FLIPr effecti... Humoral and cellular immunity in th...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-50 / 113. (共3頁) 1 2 3 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2024-09-10	Boosting DNA vaccine power by lipid nanoparticles surface engineered with amphiphilic bioresorbable copolymer	Molecular Therapy Nucleic Acids. 2024 Sep 10;35(3):Article number 102261.
2024-03-14	Lipid nanoparticle-encapsulated DNA vaccine robustly induce superior immune responses to the mRNA vaccine in Syrian hamsters	Molecular Therapy Methods and Clinical Development. 2024 Mar 14;32(1):Article number 101169.
2024-03	Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy	Nature Cancer. 2024 Mar;5(3):400-419.
2024	ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progression	American Journal of Cancer Research. 2024;14(4):1850-1865.
2023-12	A broad-spectrum pneumococcal vaccine induces mucosal immunity and protects against lethal Streptococcus pneumoniae challenge	Emerging Microbes and Infections. 2023 Dec;12(2):Article number 2272656.
2023-08-27	Co-delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1-dominant humoral and cellular immunity against SARS-CoV-2	Journal of Medical Virology. 2023 Aug 27;95(8):Article number e29040.
2023-08-16	A TLR9 agonist synergistically enhances protective immunity induced by an Alum-adjuvanted H7N9 inactivated whole-virion vaccine	Emerging Microbes and Infections. 2023 Aug 16;12(2):Article number 2249130.
2023-08	Humoral and cellular immunity in three different types of COVID-19 vaccines against SARS-CoV-2 variants in a real-world data analysis	Journal of Microbiology, Immunology and Infection. 2023 Aug;56(4):705-717.
2023-06-02	Recombinant lipidated FLIPr effectively enhances mucosal and systemic immune responses for various vaccine types	npj Vaccines. 2023 Jun 02;8:Article number 82.
2023-05-29	TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responses	International Journal of Biological Sciences. 2023 May 29;19(9):2897-2913.
2023-01-23	A flexible liposomal polymer complex as a platform of specific and regulable immune regulation for individual cancer immunotherapy	Journal of Experimental and Clinical Cancer Research. 2023 Jan 23;42:Article number 29.
2022-12-02	Omicron-specific mRNA vaccine induced cross-protective immunity against ancestral SARS-CoV-2 infection with low neutralizing antibodies	Journal of Medical Virology. 2022 Dec 2;95:Article number e28370.
2022-11-21	Formulation of SARS-CoV-2 spike protein with CpG oligodeoxynucleotides and squalene nanoparticles modulates immunological aspects following intranasal delivery	Pharmaceutics. 2022 Nov 21;14(11):Article number 2539.
2022-06-09	Induction of high affinity monoclonal antibodies against SARS-CoV-2 variant infection using a DNA prime-protein boost strategy	Journal of Biomedical Science. 2022 Jun 9;29:Article number 37.
2022-06-03	A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection	npj Vaccines. 2022 Jun 03;7:Article number 60.
2022-05-02	Furin and TMPRSS2 resistant spike induces robust humoral and cellular immunity against SARS-CoV-2 lethal infection	Frontiers in Immunology. 2022 May 2;13:Article number 872047.
2022-04-28	Low-dose SARS-CoV-2 S-trimer with an emulsion adjuvant induced th1-biased protective immunity	International Journal of Molecular Sciences. 2022 Apr 28;23(9):Article number 4902.
2022-04-22	Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants	JCI Insight. 2022 Apr 22;7(8):Article number e157597.
2021-10-11	Intranasal vaccination with recombinant antigen-FLIPr fusion protein alone induces long-lasting systemic antibody responses and broad T cell responses	Frontiers in Immunology. 2021 Oct 11;12:Article number 751883.
2021-10-05	A novel rapid test to detect anti-SARS-CoV-2 n protein IgG based on shear horizontal surface acoustic wave (SH-SAW)	Diagnostics. 2021 Oct 5;11(10):Article number 1838.
2021-10	Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironment	Journal for Immunotherapy of Cancer. 2021 Oct;9(10):Article number e002758.
2021-09-25	Assessment of adjuvantation strategy of lipid squalene nanoparticles for enhancing the immunogenicity of a SARS-CoV-2 spike subunit protein against COVID-19	International Journal of Pharmaceutics. 2021 Sep 25;607:Article number 121024.
2021-09	Squalene nanoemulsion reinforces mucosal and immunological fingerprints following intravaginal delivery	Biomedicine and Pharmacotherapy. 2021 Sep;141:Article number 111799.
2021-08-11	Characterization of virus replication, pathogenesis, and cytokine responses in syrian hamsters inoculated with SARS-CoV-2	Journal of Inflammation Research. 2021 Aug 11;14:3781-3795.
2021-07-12	A novel recombinant Fc gamma receptor-targeted survivin combines with chemotherapy for efficient cancer treatment	Biomedicines. 2021 Jul 12;9(7):Article number 806.
2021-05-27	DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss	PLoS Neglected Tropical Diseases. 2021 May 27;15(5):Article number e0009374.
2020-10-21	A polypeptide of tumor-associated antigen L6 with intrinsic adjuvant activity enhances antitumor immunity	Vaccines. 2020 Oct 21;8(4):Article number 620.
2020-10-09	Nanoemulsion adjuvantation strategy of tumor-associated antigen therapy rephrases mucosal and immunotherapeutic signatures following intranasal vaccination	Journal for ImmunoTherapy of Cancer. 2020 Oct 9;8(2):Article number e001022.
2020-04-14	Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice	Journal of Biomedical Science. 2020 Apr 14;27:Article number 51.
2020-04	Liposomal TLR9 agonist combined with TLR2 agonist-fused antigen can modulate tumor microenvironment through dendritic cells	Cancers. 2020 Apr;12(4):Article number 810.
2019-10	Domain 4 of pneumolysin from Streptococcus pneumoniae is a multifunctional domain contributing TLR4 activating and hemolytic activity	Biochemical and Biophysical Research Communications. 2019 Oct;517(4):596-602.
2019-09-01	Endoplasmic reticulum-targeting sequence enhanced the cellular immunity of a tumor-associated antigen L6-based DNA vaccine	American Journal of Cancer Research. 2019 Sep 1;9(9):2028-2036.
2019-08-02	Delivery of antigen to CD8(+) dendritic cells by fusing antigen with formyl peptide receptor-like 1 inhibitor protein induces antitumor immunity	Frontiers in Immunology. 2019 Aug 2;10:Article number 1839.
2019-04-11	Immunological evaluation of a novel HLA-A2 restricted phosphopeptide of tumor associated Antigen, TRAP1, on cancer therapy	Vaccine: X. 2019 Apr 11;1:Article number 100017.
2018-12	A therapeutic vaccine targeting HPV E6/E7 with intrinsic Toll-like receptor 2 agonist activity induces antitumor immunity	American Journal of Cancer Research. 2018 Dec;8(12):2528-2537.
2018-08	Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells	EMBO Reports. 2018 Aug;19(8):Article number e46182.
2018-04-23	Efficient uptake of recombinant lipidated survivin by antigen-presenting cells initiates antigen cross-presentation and antitumor immunity	Frontiers in Immunology. 2018 Apr 23;9:Article number 822.
2018-04-18	Polysorbasome: A colloidal vesicle contoured by polymeric bioresorbable amphiphiles as an immunogenic depot for vaccine delivery	ACS Applied Materials and Interfaces. 2018 Apr 18;10(15):12553-12561.
2017-03	Recent progress in GM-CSF-based cancer immunotherapy	Immunotherapy. 2017 Mar;9(4):347-360.
2016-12	Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer	Oncotarget. 2016 Dec;7(52):85917-85928.
2016-11-09	Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy	Scientific Reports. 2016 Nov 09;6:Article number 36732.
2016-07-29	Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice	Scientific Reports. 2016 Jul 29;6:Article number 30648.
2016-07	Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice	Cancer Letters. 2016 Jul;377(2):126-133.
2016-06	TGF-beta and IL-21 cooperatively stimulate activated CD8 T cells to differentiate into Tc17 cells	Immunology Letters. 2016 Jun;174:23-27.
2016-05-06	A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity	Journal of Controlled Release. 2016 May 6;233:57-63.
2016-05	A toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population	Oncotarget. 2016 May;7(21):30804-30819.
2016-04	Carboxyl-terminal fusion of E7 into Flagellin shifts TLR5 activation to NLRC4/NAIP5 activation and induces TLR5-independent anti-tumor immunity	Scientific Reports. 2016 Apr;6:Article number 24199.
2016-02	Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice	Vaccine. 2016 Feb;34(8):1054-1061.
2016-01	A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft model	Oncotarget. 2016 Jan;7(1):671-683.
2015-12	Recombinant bacterial lipoproteins as vaccine candidates	Expert Review of Vaccines. 2015 Dec;14(12):1623-1632.

顯示項目1-50 / 113. (共3頁) 1 2 3 > >> 每頁顯示[10|25|50]項目